Small Cap Feast
Small Cap Feast – 20 December 2018
Set Menu AIM:
Total number of AIM Companies (Incl Susp): 921
Total number of AIM Companies trading: 849*
* As at 17 December 2018
Set Menu NEX Growth:
Total number of NEX Growth Market Companies (Incl Susp): 89*
Total number of NEX Growth Market Companies trading: 87*
* As at 17 December 2018
Set Menu Standard List:
Total number of Standard List Companies (Incl Susp): 139*
Total number of Standard List Companies trading: 130*
* As at 17 December 2018
Dish of the Day:
No Joiners Today
No Joiners Today
Off the Menu:
No Leavers Today
No Leavers Today
Dish of the Day:
No Joiners Today
No Joiners Today
Off the Menu:
No Leavers Today
No Leavers Today
What’s Cooking in the IPO Kitchen?
Main Market (Specialist Funds)
The Global Sustainability Trust -aiming for attractive risk-adjusted returns by investing primarily in private market investments that are expected to have a positive environmental and social impact raising c.£200m. Due 31 Jan 2019.
PetroTal Corp is an oil and gas company whose shares are currently admitted to trading on the TSXV. The Company is focused on development of oil and gas assets in Peru and it currently has controlling interests in three onshore Peru license blocks. No new funds being raised. Due 21 Dec. Mkt cap c.£80m
Greenfields Petroleum (TSX-V:GNF) production focused company with operated assets in Azerbaijan seeking AIM dual listing including $60m private placement. Mkt cap $12.6m CAD. Expected mid December.
Advanced Medical Solutions (AMS.L) 259.5p £562m
Advanced Medical Solutions Group, the surgical and advanced wound care specialist company, announced that it has received CE approval to market and launch its LiquiBandFix8® Open Hernia Mesh Fixation Device in Europe.
The LiquiBandFix8® Open Hernia Mesh Fixation Device is used for atraumatic mesh fixation in open inguinal hernia surgery. The device optimises costs for payors due to the reduced turnaround time of patients without compromising patient care. The device will be marketed and distributed by the Group’s direct sales teams in the UK and Germany and through various distributor partners across the EU. This approval augments AMS’s existing LiquiBandFix8® laparoscopic fixation device already used in minimally invasive hernia repair.
At present, the laparoscopic device is approved for use in Europe and a number of other markets. AMS has begun the US approval process for the laparoscopic fixation device which is expected to take another two years and to cost approximately £3m as it will necessitate a full set of clinical trials. These are expected to start early next year, once Investigational Device Exemption with the FDA has been obtained.
88 Energy (88E.L) 0.94p £58.57m
88 Energy advised the following in relation to its oil and gas operations on the North Slope of Alaska.
Multiple high-quality parties active in conventional dataroom
Deadline for bids extended due to request
Deal now targeted for 1Q 2019
Initial HRZ review by Baker Hughes encouraging
Additional value add analysis now underway ahead of finalising farm-out package
Yukon Leases – 3D seismic processing continues with inversion now underway
Western Leases – Winx-1 exploration well on schedule for February 2019 spud
Real Good Food (RGD.L) 5.5p £6.16m
Real Good Food announced that it has completed the sale of R&W Scott Limited to its management team. The Group will receive consideration of £3.95m as a result of the MBO, payable by means of a cash payment of £1.5m, £0.5m of which is deferred until 30 Sept 2019, and the assumption by R&W Scott’s management team of £2.45m of third-party debt.
R&W Scott has been producing jams and preserves for over 130 years and is based out of Carluke in Lanarkshire, Scotland. R&W Scott also manufactures chocolate flavoured coatings, sweet and savoury spreads and speciality soft icings, servicing a number of sectors including retail, foodservice and wholesale customers worldwide and has been a part of the Group since the Group’s inception.
In the Group’s financial year ended 31 March 2017, R&W Scott contributed £10.36m of revenue, and incurred a loss before non-recurring items and tax of £1.22m, and a pre-tax loss of £3.3m, closing that year with net assets of £1.89m. The Group expects to incur an accounting loss for the Group on disposal of approximately £3m and a write down of parent company reserves at 31 Mar 2019 of approximately £5m.
President Energy (PPC.L) 9.55p £100m
President Energy, the upstream oil and gas company with a diverse portfolio of production and exploration assets focused primarily in Argentina, provides an update relating to the New Puesto Prado and Las Bases Concessions in Rio Negro Province, Argentina (President 90% and operator – EDHIPSA 10%).
The Puesto Prado and Las Bases Concessions (together “the New Concessions”) formally signed over to President in a ceremony attended by the Governor of Rio Negro, the Secretary of Energy of the Province, and our partners, the Provincial oil company EDHIPSA
First oil now being produced from the reactivation of the first two wells in Puesto Prado
Estancia Vieja gas has been successfully flowed to Puesto Prado and will be powering that field by end January
Chamberlin (CMH.L) 93.5p £5.57m
Chamberlin announced that it has completed the sale of Exidor Limited to ASSA ABLOY Limited, for a total enterprise value of £10m with the consideration to be paid in cash.
The proceeds of the disposal will be used to reduce Group indebtedness, to provide additional working capital and to reduce certain of the Company’s existing pension liabilities.
The cash consideration represents approximately 180% of Chamberlin’s market capitalisation based on the Group’s closing mid-market share price of 70p per ordinary share as at 18 Dec 2018.
Exidor employs approximately 70 staff from its premises in Cannock, all of whom will be retained under the ownership of ASSA ABLOY. Turnover in the year to 31 March 2018 was £7.52m and operating profit was approximately £651,000. Total net assets as at 31 March 2018 were approximately £2.01m.
i3 Energy (I3E.L) 38p £15.59m
i3 Energy, an independent oil and gas company with assets and operations in the UK, is pleased to announce that it continues to progress the necessary documentation with the UK’s Oil & Gas Authority (“OGA”) to achieve Field Development Plan (“FDP”) approval in early 2019 for the Company’s 100% owned and operated Liberator development.
i3 expects to enter the final authorisation phase of the OGA’s FDP planning and consent process in Q1 2019 and continues to position itself for mid-2019 development execution with Liberator Phase I first oil anticipated in mid-2020.
“We are pleased by the progress being made towards Liberator Phase I field development approval and are appreciative of the ongoing support and guidance of the OGA.”
Edenville Energy (EDL.L) 0.13p £2m
Edenville Energy, the company developing a coal project in southwest Tanzania, is pleased to report that, further to the announcement made on 17 Dec 2018, that the Lamella clarifier water treatment plant that has been installed at the Company’s Rukwa Coal Project is now fully operational.
The Lamella water treatment plant has been designed to enhance the quality of the water and reduce the amount used in the Project’s coal processing, along with ensuring that the Project site is following recognised international environmental practices. Management believe this plant will improve both water qualities in the plant process and in the return ponds, which in turn should lead to increased coal processing plant productivity.
W Resources (WRES.L) 0.53p £29.79m
W Resources, the tungsten, copper and gold mining company with assets in Spain and Portugal, is delighted to report that it has successfully fed the first mined ore into the newly completed crusher which is now being commissioned at its flagship tungsten and tin project, La Parrilla in Spain.
“First ore into new crusher was achieved on 18 December 2018 ahead of the January 2019 target and is a great credit to the team at La Parrilla. We wish everyone a safe and Merry Christmas and a positive New Year.”
Ten Lifestyle Group (TENG.L) 48.57p £39.3m
Ten Lifestyle Group, a leading technology-enabled lifestyle and travel platform for the world’s wealthy and mass affluent, announced that Sean Hegarty will be stepping down as CFO on 31 July 2019. The Company has now commenced a formal process to appoint a successor and a further announcement will be made in due course. Sean will remain with the Company until 31 July 2019 to ensure a smooth handover of duties.
Alex Cheatle, CEO, Ten Lifestyle Group plc, said, “Sean has been with Ten since 2012 including overseeing the IPO last year. I am very grateful for his contributions during this period and wish him every success in the future. We have already begun the search for his replacement.”
NetScientific (NSCI.L) 10p £22m
NetScientific, the transatlantic healthcare IP commercialisation group, announced that it had decided to conduct a review of the various strategic options open to it, one of which was a sale of the Company.
Today, NetScientific provides an update on progress regarding the Strategic Review.
The Company has received indications of interest in a potential acquisition of certain of the Company’s portfolio companies. However, to date, that indicative interest has not resulted in any binding or non-binding offer for any of its portfolio companies.
The Company itself is not in receipt of any approaches and is not in discussions with any potential offeror at the time of this announcement.
As at 31 Dec 2018, NetScientific is expected to have available cash resources of approximately £3m. In each of 2019 and 2020, NetScientific expects to have central costs of approximately £2m and to invest up to approximately £5m in its portfolio companies, should they fail to raise external finance.
Therefore, the Board continues to assess all of its strategic options, including seeking additional funding from its shareholders and taking material action to reduce further the Company’s costs, which may include seeking a delisting.
0203 764 2344
*A corporate client of Hybridan LLP
This document, which does not constitute research, has been issued by Hybridan LLP for information purposes only and should not be construed in any circumstances as an offer to sell or solicitation of any offer to buy any security or other financial instrument, nor shall it, or the fact of its distribution, form the basis of, or be relied upon in connection with, any contract relating to any such action. This document has no regard for the specific investment objectives, financial situation or needs of any specific person or entity and is not a personal recommendation to any such person or entity. Recipients should reach an individual investment decision, based upon their respective financial objectives and financial resources and, if any doubt, should seek advice from an investment advisor.
The information contained in this document is based on materials and sources that are believed to be reliable; however, such information has not been independently verified and therefore it is not possible to confirm such information as being accurate. This document is not intended to be a complete statement or summary of any securities, markets, reports or developments referred to herein. No representation or warranty, either express or implied, is made or accepted by Hybridan LLP, its members, officers, employees, agents or associated undertakings in relation to the accuracy, completeness or reliability of the information contained in this document, nor should it be relied upon as such.
The content of this document includes market commentary and other information which we have prepared in relation to the company referred to in this document, which is our broking client. The provision of this document to you constitutes a minor non-monetary benefit which is capable of enhancing the quality of service provided by Hybridan LLP and which is of a scale and nature which could not be judged to impair the duty of Hybridan LLP to act in the best interest of its client falling within article 24(7)(b) of Regulation 600/2014/EU (MIFID II Regulation).
Any and all opinions expressed are current as of the date appearing on this face of this document only. Any and all opinions expressed are subject to change without notice and Hybridan LLP is under no obligation to update the information contained herein. To the fullest extent permitted by law, none of Hybridan LLP, its members, officers, employees, agents or associated undertakings shall have any liability whatsoever for any direct or indirect or consequential loss or damage (including lost profits) arising in any way from use of all or any part of the information in this document.
This document should not be relied upon as being an independent or impartial view of the subject matter and, for the avoidance of doubt, constitutes non-independent research (as such term is defined in the Financial Conduct Authority’s Conduct of Business Sourcebook to reflect the requirements of the MIFID II Regulation and Directive 2014/65/EU (known as MIFID II)). The individuals who prepared this document may be interested in shares in the company concerned and/or other companies within its sector, may be involved in providing other financial services to the company or companies referenced in this document or to other companies who might be said to be competitors of the company or companies referenced in this document. As a result both Hybridan LLP and the individual members, officers and/or employees who prepared this document may have responsibilities that conflict with the interests of the persons who receive this document. Hybridan LLP and/or connected persons may, from time to time, have positions in, make a market in and/or effect transactions in any investment or related investment mentioned herein and may provide financial services to the issuers of such investments.
In the United Kingdom, this document is directed at and is for distribution only to persons who (i) fall within article 19(5) (persons who have professional experience in matters relating to investments) or article 49(2) (a) to (d) (high net worth companies, unincorporated associations, etc.) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 (SI 2005/1529) (as amended) or (ii) persons who are each a professional client or eligible counterparty (as those terms are defined in the Financial Conduct Authority’s Conduct of Business Sourcebook) of Hybridan LLP (all such persons referred to in (i) and (ii) together being referred to as relevant persons). This document must not be acted on or relied up on by persons who are not relevant persons. For the purposes of clarity, this document is not intended for and should not be relied upon by any person who would be classified as a retail client under the Financial Conduct Authority’s Conduct of Business Sourcebook.
Neither this document, nor any copy of part thereof may be distributed in any other jurisdictions where its distribution may be restricted by law and persons into whose possession this document comes should inform themselves about, and observe, any such restrictions. Distribution of this report in any such other jurisdictions may constitute a violation of territorial and/or extra-territorial securities laws, whether in the United Kingdom, the United States or any other jurisdiction in any part of the world.
Where possible this document is made available to all relevant recipients at the same time. Dissemination of research by Hybridan LLP is monitored to ensure that it is only provided to relevant persons. Research prepared by Hybridan LLP is not intended to be received and/or used by any person who is a retail client.
Hybridan LLP and/or its associated undertakings may from time-to-time provide investment advice or other services to, or solicit such business from, any of the companies referred to in this document. Accordingly, information may be available to Hybridan LLP that is not reflected in this material and Hybridan LLP may have acted upon or used the information prior to or immediately following its publication. In addition, Hybridan LLP, the members, officers and/or employees thereof and/or any connected persons may have an interest in the securities, warrants, futures, options, derivatives or other financial instrument of any of the companies referred to in this document and may from time-to-time add or dispose of such interests.
This document may not be copied, redistributed, resent, forwarded, disclosed or duplicated in any form or by any means, whether in whole or in part other than with the prior written consent of Hybridan LLP.
MIFID II status of Hybridan LLP research
The cost of production of our corporate research is met by retainers from our corporate broking clients. In addition, from time to time we issue further communications as market commentary (such as our daily newsletter, Small Cap Breakfast), which we consider to constitute a minor non-monetary benefit which is capable of enhancing the quality of service provided by Hybridan LLP and which is of a scale and nature which could not be judged to impair the duty of Hybridan LLP to act in the best interest of its client falling within article 24(7)(b) of the MIFID II Regulation.
Hybridan LLP is a limited liability partnership registered in England and Wales, registered number OC325178, and is authorised and regulated by the Financial Conduct Authority and is a member of the London Stock Exchange. Any reference to a partner in relation to Hybridan LLP is to a member of Hybridan LLP or an employee with equivalent standing and qualifications. A list of the members of Hybridan LLP is available for inspection at the registered office, 2 Jardine House, The Harrovian Business Village, Bessborough Road, Harrow, Middlesex HA1 3EX.
If you would like to unsubscribe, please email email@example.com with “unsubscribe me”.